Brivanib
For research use only. We do not sell to patients. Brivanib CAS No. : 649735-46-6 Biological Activity:Brivanib (BMS-540215) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM, and has moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Research Area:Cancer Targets:Autophagy|VEGFR Related Screening Libraries:Drug Repurposing Compound Library Plus;Clinical Compound Library Plus;Bioactive […]